CellCarta and Imagene AI Expand AI Biomarker Collaboration

This collaboration enhances drug development by validating and scaling AI-powered diagnostics for improved healthcare outcomes.

Auto-scored: Positive business expansion in AI diagnostics with no apparent risk or negative implications.